Harper James advises UK businesses on employee share schemes, including EMI option schemes, growth shares and the company approvals needed to issue or transfer shares. The valuation placed on a company’s shares affects the tax treatment, exercise price, dilution and perceived value of awards made to employees.
For an EMI option scheme, the company normally establishes the shares’ unrestricted market value and actual market value at the date of the grant. The valuation supports the exercise price and can be submitted to HMRC for agreement before options are granted. If the exercise price is below the relevant market value, the discount is generally treated as employment income when the option is exercised. A properly documented valuation therefore gives the company and option holder a clearer basis for assessing the tax position.
A higher valuation usually produces a higher exercise price. This reduces the immediate economic benefit of the option, although it also reflects stronger company performance. A lower valuation produces a lower exercise price, but it must be supported by the company’s financial position, trading prospects, share rights and recent investment transactions. An outdated or unsupported valuation creates uncertainty over the tax treatment and the value represented by the award.
Valuation is also central to growth shares. These shares normally carry an entitlement to value created above a specified hurdle. The hurdle is set by reference to the company’s value when the shares are issued. If it is set too low, existing shareholders transfer more value than intended. If it is set too high, employees receive an award with limited practical value. The company must also assess the impact of issuing shares on the cap table, voting rights, future fundraising and the rights contained in its articles of association and shareholder agreement.
The board should record the valuation method, assumptions, relevant financial information, share rights and any recent funding or arm’s-length transaction. The valuation should be reviewed when there has been a material change, such as a funding round, acquisition offer or substantial change in trading performance. The company should then align the valuation with the option agreement, shareholder approvals, Companies House records and employee communications. This process links the legal documents to the commercial value of the scheme and gives employees a clear explanation of what their award represents.